Nifty
:
25891.40
Sensex
:
84556.40
22.80 (0.09%)
130.06 (0.15%)
Nifty
Sensex
:
:
25891.40
84556.40
22.80 (0.09%)
130.06 (0.15%)

Titan Bio-Tech Ltd.

Chemicals

Rating :
55/99

BSE: 524717 | NSE: Not Listed

NSE BSE
1189.95
23-Oct-2025
  • Open
  • High
  • Low
  • Previous Close
  •  1189.95
  •  1189.95
  •  1189.95
  •  1214.20
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  5048
  •  6006867
  •  1189.95
  •  0

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 983.34
  • 44.71
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 979.88
  • 0.17%
  • 6.16

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 55.78%
  • 2.18%
  • 29.65%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 12.39%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.08
  • 1.92
  • 2.80

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 20.59
  • -11.25
  • -2.94

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 26.29
  • -9.65
  • -4.57

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.76
  • 10.24
  • 16.73

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.42
  • 2.95
  • 3.04

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.48
  • 9.50
  • 12.17

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Net Sales
46.50
43.11
7.86%
35.17
39.92
-11.90%
38.28
45.98
-16.75%
39.89
43.43
-8.15%
Expenses
37.76
34.86
8.32%
30.60
32.84
-6.82%
33.43
35.38
-5.51%
32.13
34.71
-7.43%
EBITDA
8.74
8.25
5.94%
4.57
7.08
-35.45%
4.85
10.60
-54.25%
7.76
8.71
-10.91%
EBIDTM
18.79%
19.13%
12.99%
17.73%
12.66%
23.06%
19.45%
20.06%
Other Income
0.72
0.62
16.13%
1.38
0.48
187.50%
1.59
0.44
261.36%
0.32
0.55
-41.82%
Interest
0.20
0.31
-35.48%
0.08
0.34
-76.47%
0.15
0.26
-42.31%
0.27
0.28
-3.57%
Depreciation
1.15
1.05
9.52%
0.84
0.84
0.00%
1.18
0.84
40.48%
1.10
0.86
27.91%
PBT
8.11
7.52
7.85%
5.03
6.38
-21.16%
5.10
9.94
-48.69%
6.72
8.13
-17.34%
Tax
1.95
1.82
7.14%
1.26
1.53
-17.65%
1.30
2.56
-49.22%
1.71
2.10
-18.57%
PAT
6.16
5.70
8.07%
3.77
4.84
-22.11%
3.80
7.38
-48.51%
5.00
6.03
-17.08%
PATM
13.25%
13.22%
10.71%
12.13%
9.93%
16.06%
12.54%
13.88%
EPS
8.30
7.74
7.24%
4.90
6.05
-19.01%
5.31
8.68
-38.82%
8.10
7.89
2.66%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
159.84
156.45
164.07
144.00
123.55
142.24
79.44
64.91
57.37
52.74
45.77
Net Sales Growth
-7.31%
-4.64%
13.94%
16.55%
-13.14%
79.05%
22.38%
13.14%
8.78%
15.23%
 
Cost Of Goods Sold
74.82
72.62
75.58
69.79
57.56
59.88
39.35
32.70
31.77
32.85
29.62
Gross Profit
85.02
83.83
88.49
74.21
66.00
82.36
40.09
32.21
25.60
19.89
16.16
GP Margin
53.19%
53.58%
53.93%
51.53%
53.42%
57.90%
50.47%
49.62%
44.62%
37.71%
35.31%
Total Expenditure
133.92
131.02
129.79
114.48
92.28
96.05
65.95
56.00
50.39
47.37
41.86
Power & Fuel Cost
-
9.83
10.24
8.98
6.67
4.19
3.59
3.25
3.19
2.09
1.84
% Of Sales
-
6.28%
6.24%
6.24%
5.40%
2.95%
4.52%
5.01%
5.56%
3.96%
4.02%
Employee Cost
-
26.38
23.71
18.21
14.24
13.09
11.51
9.43
6.61
2.89
3.45
% Of Sales
-
16.86%
14.45%
12.65%
11.53%
9.20%
14.49%
14.53%
11.52%
5.48%
7.54%
Manufacturing Exp.
-
7.84
8.83
7.58
6.57
11.61
5.09
4.72
3.73
5.37
2.96
% Of Sales
-
5.01%
5.38%
5.26%
5.32%
8.16%
6.41%
7.27%
6.50%
10.18%
6.47%
General & Admin Exp.
-
5.08
4.10
3.01
2.28
2.56
3.76
3.96
3.13
2.25
2.02
% Of Sales
-
3.25%
2.50%
2.09%
1.85%
1.80%
4.73%
6.10%
5.46%
4.27%
4.41%
Selling & Distn. Exp.
-
8.64
6.68
6.21
4.61
4.00
2.48
1.58
1.84
1.76
1.88
% Of Sales
-
5.52%
4.07%
4.31%
3.73%
2.81%
3.12%
2.43%
3.21%
3.34%
4.11%
Miscellaneous Exp.
-
0.64
0.64
0.71
0.34
0.72
0.17
0.37
0.12
0.16
1.88
% Of Sales
-
0.41%
0.39%
0.49%
0.28%
0.51%
0.21%
0.57%
0.21%
0.30%
0.22%
EBITDA
25.92
25.43
34.28
29.52
31.27
46.19
13.49
8.91
6.98
5.37
3.91
EBITDA Margin
16.22%
16.25%
20.89%
20.50%
25.31%
32.47%
16.98%
13.73%
12.17%
10.18%
8.54%
Other Income
4.01
3.91
1.75
1.94
0.94
0.79
0.45
0.69
0.45
0.28
0.55
Interest
0.70
0.80
1.17
0.75
0.87
1.73
2.35
2.34
2.39
1.48
1.03
Depreciation
4.27
4.17
3.33
2.60
2.37
2.22
1.80
1.71
0.93
0.82
0.77
PBT
24.96
24.37
31.53
28.12
28.97
43.03
9.79
5.54
4.10
3.35
2.65
Tax
6.22
6.10
7.87
7.09
7.28
11.00
2.57
1.63
1.43
1.17
0.88
Tax Rate
24.92%
25.03%
24.96%
25.21%
25.13%
25.76%
24.71%
29.42%
34.88%
34.93%
33.21%
PAT
18.73
18.27
23.66
21.02
21.68
30.34
7.07
3.52
2.55
2.18
1.77
PAT before Minority Interest
18.73
18.27
23.66
21.02
21.68
31.71
7.84
3.91
2.67
2.18
1.77
Minority Interest
0.00
0.00
0.00
0.00
0.00
-1.37
-0.77
-0.39
-0.12
0.00
0.00
PAT Margin
11.72%
11.68%
14.42%
14.60%
17.55%
21.33%
8.90%
5.42%
4.44%
4.13%
3.87%
PAT Growth
-21.80%
-22.78%
12.56%
-3.04%
-28.54%
329.14%
100.85%
38.04%
16.97%
23.16%
 
EPS
22.57
22.01
28.51
25.33
26.12
36.55
8.52
4.24
3.07
2.63
2.13

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
153.40
133.45
109.91
86.24
68.76
39.19
32.18
24.36
23.01
21.53
Share Capital
8.26
8.26
8.26
8.26
8.26
8.26
8.26
7.74
7.74
7.74
Total Reserves
145.14
125.19
101.65
77.98
60.49
30.93
23.91
16.62
15.27
13.79
Non-Current Liabilities
3.57
4.00
4.25
4.90
8.96
14.06
15.19
20.25
15.79
4.74
Secured Loans
0.18
0.45
0.30
1.08
2.24
2.60
3.22
4.02
3.62
0.33
Unsecured Loans
0.00
0.00
0.00
0.00
2.62
8.96
9.95
13.85
11.56
3.95
Long Term Provisions
1.63
1.48
1.62
1.43
1.32
1.28
0.98
1.62
0.00
0.00
Current Liabilities
23.71
27.36
27.54
23.99
29.78
22.44
16.97
12.09
12.25
12.66
Trade Payables
5.22
3.37
5.55
4.16
3.71
4.12
2.14
1.09
1.40
1.71
Other Current Liabilities
10.34
9.35
8.91
7.47
6.75
4.58
3.78
2.82
1.86
2.34
Short Term Borrowings
1.54
6.30
5.53
4.72
8.29
11.34
9.68
7.10
7.28
7.13
Short Term Provisions
6.60
8.35
7.55
7.64
11.03
2.39
1.37
1.08
1.71
1.48
Total Liabilities
180.68
164.81
141.70
115.13
111.22
78.04
65.92
57.89
52.18
40.06
Net Block
57.27
52.01
35.89
34.99
33.61
31.16
29.02
13.68
12.85
11.27
Gross Block
80.75
71.33
52.46
48.97
45.51
40.85
36.90
21.74
19.98
17.58
Accumulated Depreciation
23.48
19.32
16.57
13.98
11.90
9.69
7.89
8.06
7.13
6.32
Non Current Assets
95.67
84.41
66.21
44.34
41.89
31.84
29.59
27.53
22.63
16.26
Capital Work in Progress
1.70
2.55
13.29
3.63
0.27
0.07
0.00
13.31
9.32
4.55
Non Current Investment
32.77
28.19
15.41
4.03
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
1.91
1.29
1.35
1.52
7.83
0.61
0.57
0.54
0.47
0.41
Other Non Current Assets
2.02
0.36
0.26
0.16
0.18
0.00
0.00
0.00
0.00
0.04
Current Assets
85.01
80.41
75.49
70.79
69.33
46.21
36.33
30.35
29.54
23.78
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
50.72
45.57
36.17
34.68
32.54
27.98
21.13
17.58
14.50
10.99
Sundry Debtors
18.82
18.66
21.01
16.36
18.10
11.86
9.24
7.77
6.34
5.92
Cash & Bank
5.56
3.29
4.86
6.81
5.45
1.86
2.04
1.24
4.30
3.56
Other Current Assets
9.91
0.49
0.51
5.63
13.24
4.51
3.92
3.75
4.40
3.32
Short Term Loans & Adv.
9.49
12.40
12.94
7.31
13.12
4.41
3.79
3.59
2.83
1.16
Net Current Assets
61.30
53.05
47.95
46.81
39.55
23.77
19.36
18.26
17.29
11.12
Total Assets
180.68
164.82
141.70
115.13
111.22
78.05
65.93
57.89
52.18
40.05

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
20.12
21.15
21.18
22.04
19.08
6.12
5.47
1.90
0.13
4.79
PBT
24.37
31.53
28.12
28.97
42.71
10.40
5.54
4.10
3.35
2.65
Adjustment
5.29
4.76
3.52
3.52
4.16
4.40
4.21
3.47
2.29
1.77
Changes in Working Capital
-3.55
-7.28
-2.96
-3.33
-16.90
-6.50
-3.09
-4.60
-4.50
1.16
Cash after chg. in Working capital
26.11
29.02
28.68
29.16
29.97
8.30
6.66
2.97
1.14
5.58
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-5.99
-7.87
-7.50
-7.12
-10.88
-2.19
-1.20
-1.08
-1.01
-0.79
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-9.87
-20.30
-20.73
-16.44
-4.86
-2.21
-4.11
-5.57
-8.39
-4.96
Net Fixed Assets
-8.57
-8.13
-13.15
-13.64
-4.17
-1.08
-1.50
-4.90
-6.24
Net Investments
-1.32
-11.59
-7.56
-2.76
0.00
0.00
0.00
0.00
0.00
Others
0.02
-0.58
-0.02
-0.04
-0.69
-1.13
-2.61
-0.67
-2.15
Cash from Financing Activity
-7.96
-2.87
-2.40
-4.10
-10.60
-3.95
-0.22
0.23
8.87
2.01
Net Cash Inflow / Outflow
2.29
-2.02
-1.95
1.51
3.62
-0.04
1.14
-3.44
0.62
1.85
Opening Cash & Equivalents
2.84
4.86
6.81
5.31
1.83
1.87
0.74
4.18
3.56
1.71
Closing Cash & Equivalent
5.13
2.84
4.86
6.81
5.45
1.83
1.87
0.74
4.18
3.56

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
185.63
161.49
133.00
104.36
83.21
47.42
38.93
31.46
29.72
27.81
ROA
10.58%
15.44%
16.37%
19.16%
33.50%
10.89%
6.32%
4.85%
4.73%
4.81%
ROE
12.74%
19.45%
21.44%
27.98%
58.74%
21.97%
13.84%
11.27%
9.80%
8.42%
ROCE
17.00%
25.39%
27.40%
33.74%
60.80%
21.45%
14.88%
13.59%
12.32%
12.06%
Fixed Asset Turnover
2.06
2.65
2.84
2.62
3.29
2.04
2.21
2.79
2.81
2.88
Receivable days
43.71
44.12
47.36
50.91
38.45
48.49
47.85
44.28
42.44
46.03
Inventory Days
112.33
90.92
89.79
99.29
77.64
112.82
108.86
100.62
88.20
82.32
Payable days
21.58
21.53
25.39
24.97
23.89
29.07
10.07
9.45
11.72
13.79
Cash Conversion Cycle
134.47
113.51
111.76
125.23
92.20
132.24
146.63
135.44
118.91
114.56
Total Debt/Equity
0.01
0.05
0.06
0.09
0.21
0.61
0.74
1.06
0.98
0.53
Interest Cover
31.39
27.95
38.69
34.22
25.72
5.43
3.37
2.71
3.26
3.57

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Titan Bio-Tech - Quarterly Results
    13th Aug 2025, 16:24 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.